Devices and methods for regulating temperature of organs during or before surgical procedures
US-2024000067-A1 · Jan 4, 2024 · US
US10123528B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10123528-B2 |
| Application number | US-201314083581-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 19, 2013 |
| Priority date | Nov 30, 2012 |
| Publication date | Nov 13, 2018 |
| Grant date | Nov 13, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A method for preserving erythrocytes comprising the steps of obtaining an erythrocyte concentrate; subjecting the erythrocyte concentrate to a gas system that includes 65% to 100% by volume and optionally one or more ballast gases from 0% to 35% by volume; and, maintaining the erythrocyte concentrate that has been subjected to the gas system at a temperature that is above the freezing point of the erythrocyte concentrate and up to a temperature of about 30° C.
Opening claim text (preview).
What is claimed: 1. A method for preserving erythrocytes for later transfusion by reducing hemolysis and increasing the ATP content of stored erythrocyte concentrate comprising the steps of: a. obtaining an erythrocyte concentrate for use in a transfusion; b. placing said erythrocyte concentrate in a container, said container permeable to gas, said container containing said erythrocyte concentrate, and said container absent a plasticizer that includes bis (2-ethylhexyl) phthalate; c. removing at least 70% of oxygen from the erythrocyte concentrate while said erythrocyte concentrate is in said container, said oxygen removed from said erythrocyte concentrate and said container by diffusion of said oxygen through said container; d. subjecting the erythrocyte concentrate while in said container to a gas system at a pressure of at least 1 atm, and less than 6 atm, to thereby cause said gas system to diffuse through said container and interact with said erythrocyte concentrate in said container, said gas system includes xenon, said step of subjecting said erythrocyte concentrate to said gas system occurring after said step of removing oxygen from said erythrocyte concentrate, said xenon in said gas system at a concentration of 65% to 100% by volume, said gas system added to said erythrocyte concentrate at a temperature of not more than about 30° C.; e. cooling and then maintaining the erythrocyte concentrate that has been subjected to the gas system at a temperature that is above the freezing point of the erythrocyte concentrate and up to a temperature of about 6° C.; and, f. maintaining said erythrocyte concentrate in said container for a period of up to 42 days without considerable degradation of erythrocytes quality and with less than 0.8% hemolysis of said erythrocytes such that said erythrocyte concentrate in said container can be used for said later transfusion. 2. The method as defined in claim 1 , wherein said gas system includes less than 5% by volume oxygen. 3. The method as defined in claim 1 , wherein 70-100% of the oxygen from the erythrocyte concentrate is removed prior to adding said gas system to said erythrocyte concentrate. 4. The method as defined in claim 3 , wherein said step of removing oxygen occurs in a vacuum environment. 5. The method as defined in claim 1 , wherein said gas system is added to said erythrocyte concentrate at a pressure of at least 1 to about 2 atm. 6. The method as defined in claim 1 , wherein said gas system is added to said erythrocyte concentrate at a pressure of at least 1 to about 3 atm. 7. The method as defined in claim 1 , wherein said erythrocyte concentrate is absent bis (2-ethylhexyl) phthalate plasticizer. 8. The method as defined in claim 1 , further including the step of agitating said erythrocyte concentrate in a container a) prior to addition of said gas system to said erythrocyte concentrate, b) after said addition of said gas system to the erythrocyte concentrate, and combinations thereof. 9. The method as defined in claim 1 , wherein the pressure of the gas system when being introduced to said erythrocyte concentrate is 1-4 atm. 10. The method as defined in claim 1 , wherein a temperature of said erythrocyte concentrate when said gas system is introduced to said erythrocyte concentrate is above the freezing point of the erythrocyte concentrate and no greater than about 23° C. 11. The method as defined in claim 10 , wherein said temperature of said erythrocyte concentrate is maintained at a constant temperature or has a variable temperature while said gas system is introduced to said erythrocyte concentrate. 12. The method as defined in claim 1 , wherein a temperature of said erythrocyte concentrate after addition of said gas system is no greater than about 20° C. 13. The method as defined in claim 12 , wherein said step of cooling said erythrocyte concentrate after addition of said gas system occurs in a cooling chamber, said cooling chamber is designed to store said cooled erythrocyte concentrate for up to 42 days. 14. The method as defined in claim 1 , wherein said gas system includes 0.1-35% of at least one ballast gas and said ballast gas is nitrogen, argon or mixtures thereof. 15. The method as defined in claim 1 , wherein at least a portion of said container is permeable to said gas mixture and said gas mixture is introduced into and removed from said container via diffusion through said container. 16. The method as defined in claim 1 , wherein said container is positioned in a hermetically-sealed vessel equipped with a cover that is permeable to said gas mixture, and said vessel is not permeable to said gas mixture. 17. The method as defined in claim 1 , wherein said erythrocyte concentrate in said container is kept in said gas mixture and under a pressure above 1 atm without additional pumping of said gas mixture while said container is positioned in said hermetically-sealed chamber, and cooling of erythrocyte concentrate is started from a moment of gas mixture pressure stabilization in said hermetically-sealed chamber, with said stabilization resulting from saturation of erythrocyte concentrate said gas mixture. 18. The method as defined in claim 1 , wherein a bag is made of polyvinylchloride. 19. A method for preserving erythrocytes for later transfusion by reducing hemolysis and increasing the ATP content of stored erythrocyte concentrate comprising the steps of: a. obtaining an erythrocyte concentrate that is positioned in a gas permeable bag, said erythrocyte concentrate and said bag absent a plasticizer that includes bis (2-ethylhexyl) phthalate; b. removing 70-100% of the oxygen from the erythrocyte concentrate, said step of removing oxygen from the erythrocyte concentrate occurs while said erythrocyte concentrate is in said bag, said oxygen removed from said erythrocyte concentrate and said bag by diffusion of said oxygen through said bag; c. subjecting the erythrocyte concentrate to a gas system while in said bag at a pressure of at least 1 atm, and less than 6 atm, to thereby cause said gas system to diffuse through said bag and interact with said erythrocyte concentrate in said bag, said gas system added to said erythrocyte concentrate at a pressure of above 1 atm, a temperature of said erythrocyte concentrate when said gas system is introduced to said erythrocyte concentrate is above the freezing point of said erythrocyte concentrate and no greater than about 23° C., said gas system includes 65-100% by volume xenon, 0-35% by volume of at least one ballast gas, and less than 5% by volume oxygen, said ballast gas including one or more gasses selected from the group consisting of nitrogen, noble gas other than xenon, and carbon dioxide, said step of removing oxygen from the erythrocyte concentrate occurring prior to said step of adding said gas system to said erythrocyte concentrate; d. cooling said erythrocyte concentrate after addition of said gas system to a temperature above the freezing point of the erythrocyte concentrate and no greater than about 6° C.; and, e. maintaining said erythrocyte concentrate in said container for a period of up to 42 days without considerable degradation of erythrocytes quality and with less than 0.8% hemolysis of said erythrocytes such that said erythrocyte concentrate in said container can be used for said later transfusion. 20. The method as defined in claim 19 , wherein said step of removing oxygen occurs in a vacuum environment. 21. The method as defined in claim 20 , wherein said gas system
for collecting, storing or administering blood, plasma or medical fluids {(multiple bags systems for separating or storing blood components A61M1/0209); Infusion or perfusion containers} · CPC title
Human Necessities · mapped topic
Preservation of living parts · CPC title
Non-refrigerated containers specially adapted for transporting or storing living parts whilst preserving · CPC title
Pressure processes, e.g. following predefined pressure changes over time · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.